AKT1 and neoplasm: During the phase of rapamycin treatment, experimental animals have estrous cycle disorder, sudden weight loss, etc.69; the activity of the PTEN-PI3K-AKT pathway was enhanced in dividing tumor cells and stem cells, so either artificial inhibition or activation of those pathways will bring about unpredictable physiological risks.